Literature DB >> 29490368

Enthusiasm and Skepticism About Using National Registers to Analyze Psychotropic Drug Outcomes.

Stefan Leucht1, John M Davis2,3.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29490368     DOI： 10.1001/jamapsychiatry.2017.4704

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  3 in total

1.  Evaluation of Differences in Individual Treatment Response in Schizophrenia Spectrum Disorders: A Meta-analysis.

Authors:  Stephanie Winkelbeiner; Stefan Leucht; John M Kane; Philipp Homan
Journal:  JAMA Psychiatry       Date:  2019-10-01       Impact factor: 21.596

Review 2.  Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases.

Authors:  Zheng Chang; Laura Ghirardi; Patrick D Quinn; Philip Asherson; Brian M D'Onofrio; Henrik Larsson
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

3.  Use of long acting antipsychotics and relationship to newly diagnosed bipolar disorder: a pragmatic longitudinal study based on a Canadian health registry.

Authors:  Emmanuel Stip; Syed Javaid; Jonathan Bayard-Diotte; Karim Abdel Aziz; Danilo Arnone
Journal:  Ther Adv Psychopharmacol       Date:  2020-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.